Klyuchnikov E, Langebrake C, Badbaran A, Dadkhah A, et al. Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR. Eur J Haematol 2023;110:188-197.
PMID: 36335432